Bayer partners with Population Health Research Institute on COVID-19 research
Two clinical research studies in the programme will assess the safety and efficacy of different combination therapies
Read More
Tag: Population Health Research Institute
- NICE backs daratumumab quadruplet for newly diagnosed transplant‑ineligible myeloma
- Anocca doses first patients with precision TCR‑T therapy
- Connecta launches phase 2a trial of neuroplasticity modulator
- Aquipta recommended by NICE for acute migraine treatment
- Talvey accepted for use in Scotland for relapsed and refractory multiple myeloma
